1d ), while patients with poorly differentiated tumours (G3) showed a trend towards higher BSP level compared to patients with moderately differentiated tumours (G2, Supplementary Fig. 1e ).
← all excerpts
Elevated serum levels of bone sialoprotein (BSP) predict long-term mortality in patients with pancreatic adenocarcinoma.
1
—
—